Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE)

1 filings reported holding CUE - Cue Biopharma, Inc. - Common Stock, $0.001 par value per share as of Q4 2023.
Cue Biopharma, Inc. - Common Stock, $0.001 par value per share (CUE) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 14.6K shares of 43.4M outstanding shares and own 0.03% of the company stock.
Largest 10 shareholders include Slate Path Capital LP (2.4M shares), BlackRock Inc. (2.34M shares), VANGUARD GROUP INC (2.13M shares), Bleichroeder LP (1.76M shares), GEODE CAPITAL MANAGEMENT, LLC (813K shares), STATE STREET CORP (684K shares), Robertson Stephens Wealth Management, LLC (479K shares), DIMENSIONAL FUND ADVISORS LP (458K shares), NORTHERN TRUST CORP (381K shares), and Monaco Asset Management SAM (342K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.